Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-11-15 10:35 am Sale | 13G | MARINUS PHARMACEUTICALS INC MRNS | PRUDENTIAL FINANCIAL INC PRU | 385,250 0.700% | -2,924,741 (-88.36%) | View |
| 2024-11-14 6:39 pm Purchase | 13G | MARINUS PHARMACEUTICALS INC MRNS | Sofinnova Investments Inc. | 4,386,177 8.000% | 4,386,177 (New Position) | View |
| 2024-11-14 3:04 pm Sale | 13G | MARINUS PHARMACEUTICALS INC MRNS | Cormorant Asset Management LP | 0 0.000% | -3,250,000 (Position Closed) | View |
| 2024-11-14 12:24 pm Sale | 13G | MARINUS PHARMACEUTICALS INC MRNS | EVENTIDE ASSET MANAGEMENT LLC | 0 0.000% | -4,529,997 (Position Closed) | View |
| 2024-11-14 09:34 am Sale | 13G | MARINUS PHARMACEUTICALS INC MRNS | Avoro Capital Advisors LLC | 0 0.000% | -3,150,000 (Position Closed) | View |
| 2024-11-12 4:01 pm Unchanged | 13G | MARINUS PHARMACEUTICALS INC MRNS | VANGUARD GROUP INC | 2,802,965 5.080% | 0 (Unchanged) | View |
| 2024-11-12 09:55 am Sale | 13G | MARINUS PHARMACEUTICALS INC MRNS | JENNISON ASSOCIATES LLC | 0 0.000% | -2,959,161 (Position Closed) | View |
| 2024-11-04 1:43 pm Purchase | 13G | MARINUS PHARMACEUTICALS INC MRNS | VANGUARD GROUP INC | 2,802,965 5.080% | 2,802,965 (New Position) | View |
| 2024-11-01 8:30 pm Purchase | 13G | MARINUS PHARMACEUTICALS INC MRNS | Panacea Innovation Ltd | 5,500,000 9.980% | 5,500,000 (New Position) | View |
| 2024-07-08 4:32 pm Sale | 13G | MARINUS PHARMACEUTICALS INC MRNS | BlackRock Inc. BLK | 1,869,949 3.400% | -2,729,329 (-59.34%) | View |
| 2024-04-25 5:51 pm Purchase | 13G | MARINUS PHARMACEUTICALS INC MRNS | CITADEL ADVISORS LLC | 222,335 0.400% | 222,335 (New Position) | View |
| 2024-04-19 06:04 am Purchase | 13G | MARINUS PHARMACEUTICALS INC MRNS | TANG CAPITAL PARTNERS LP | 4,502,857 8.200% | 4,502,857 (New Position) | View |
| 2024-02-14 4:18 pm Sale | 13G | MARINUS PHARMACEUTICALS INC MRNS | Lion Point Capital LP | 2,134,337 3.900% | -2,645,311 (-55.35%) | View |
| 2024-02-14 3:07 pm Purchase | 13G | MARINUS PHARMACEUTICALS INC MRNS | Cormorant Asset Management LP | 3,250,000 5.960% | 450,000 (+16.07%) | View |
| 2024-02-14 12:18 pm Purchase | 13G | MARINUS PHARMACEUTICALS INC MRNS | EVENTIDE ASSET MANAGEMENT LLC | 4,529,997 8.300% | 1,379,997 (+43.81%) | View |
| 2024-02-14 10:35 am Purchase | 13G | MARINUS PHARMACEUTICALS INC MRNS | PRUDENTIAL FINANCIAL INC PRU | 3,309,991 6.070% | 3,309,991 (New Position) | View |
| 2024-02-14 10:06 am Sale | 13G | MARINUS PHARMACEUTICALS INC MRNS | Point72 Asset Management L.P. | 493,400 0.900% | -3,021,956 (-85.96%) | View |
| 2024-02-14 09:04 am Unchanged | 13G | MARINUS PHARMACEUTICALS INC MRNS | Avoro Capital Advisors LLC | 3,150,000 5.800% | 0 (Unchanged) | View |
| 2024-02-13 12:13 pm Purchase | 13G | MARINUS PHARMACEUTICALS INC MRNS | SUVRETTA CAPITAL MANAGEMENT LLC | 5,463,641 9.990% | 491,981 (+9.90%) | View |
| 2024-02-08 1:56 pm Purchase | 13G | MARINUS PHARMACEUTICALS INC MRNS | JENNISON ASSOCIATES LLC | 2,959,161 5.400% | 2,959,161 (New Position) | View |